Study spanning 2 decades offers insights into pediatric psoriasis trendsJuly 8, 2021Psoriatic Arthritis
Malignancy risk: Secukinumab shows long-term safety for psoriasis, PsA, ankylosing spondylitisJuly 1, 2021Psoriatic Arthritis
Guselkumab induces robust reduction in acute-phase proteins and effector cytokines in PsAJune 24, 2021Psoriatic Arthritis
PsA: Apremilast linked with weight loss and improvement in disease activityJune 24, 2021Psoriatic Arthritis
TNFi+csDMARD combination provides better clinical response than TNFi monotherapy in PsAJune 24, 2021Psoriatic Arthritis
Long-term apremilast monotherapy shows promise in DMARD-naive patients with PsAJune 24, 2021Psoriatic Arthritis
